PMC:3852299 / 49324-50532 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/3852299","sourcedb":"PMC","sourceid":"3852299","source_url":"http://www.ncbi.nlm.nih.gov/pmc/3852299","text":"Abbreviations\nACTH: Adrenocorticotrophic hormone; ASD: Autism spectrum disorder; CBG: Corticosteroid binding globulin; CBP: Corticosteroid binding protein; CRH: Corticotrophin releasing hormone; CSF: Cerebral spinal fluid; DAT: Dopamine transporter; ERE: Estrogen response element; G6Pase: Glucose-6-phosphatase; GR: Glucocorticoid receptor; GRE: Glucocorticoid response elements; 5-HIAA: 5-hydroxyindolacetic; 11β-HSD: 11β-hydroxysteroid dehydrogenase; 5-HT: 5-hydroxytryptamine; 5-HTTP: 5-hydroxytryptophan; 5-HTTLP: Serotonin transporter gene promoter region; HPA: Human hypothalamic axis; IFN-γ: Interferon-γ; IL: Interleukin; MAPK: Mitogen-activated protein kinase; NADP(H): Nicotinamide adenine dinucleotide phosphate reduced; NET: Noradrenaline transporter; PDD-NOS: Pervasive developmental disorder not otherwise specified; PET: Positron emission tomograhy; PEPCK-C: Phosphoenolpyruvate carboxykinase; PK: Protein kinase; SERT: Serotonin reuptake transporter; SNP: Single nucleotide polymorphism; SSRI: Selective serotonin reuptake inhibitor; SLC6A4: Solute carrier family 6 (neurotransmitter transporter, serotonin), member 4; TNF-α: Tumour necrosis factor-α; VNT: Variable number of tandem repeats.","divisions":[{"label":"Title","span":{"begin":0,"end":13}}],"tracks":[]}